
- Telehealth Visits
- Insurance plan information

Katherine Wai, MD
Head and Neck Surgical Oncology- Telehealth Visits
- Insurance plan information



Katherine Wai, MD
Head and Neck Surgical Oncology- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Otolaryngology, American Board of Otolaryngology
Fellowship
- Otolaryngology-Head and Neck Surgery, Stanford Univ School of Medicine
Residency
- OTOLARYNGOLOGY-HEAD AND NECK SURGERY, UCSF School of Medicine -GME
Degree
- MD, UCSF School of Medicine
Academic title
- Clinical Professor
My expertise
Specialties
Locations
My research
Publications
Showing 1-6 of 25 reviews
- May 5, 20265 out of 5 Stars
Dr. Wai is super sharp, explains things clearly and not over simplified, I like the way she thinks and I'm very happy with my surgery outcome. Great surgeon plus she's personable AND a listener too. 10/10
- May 5, 20265 out of 5 Stars
Dr. Wai and her immediate Team are incredible!
- April 28, 20265 out of 5 Stars
She was very friendly, but concerned about my condition. I wish I was closer to Ucsf so I could see her in person as I live far away.
- April 21, 20265 out of 5 Stars
Exceptionally friendly, concerned, informative doctors and advice.
- April 16, 20265 out of 5 Stars
Dr. Wai is kind, thorough and very skilled.
- April 15, 20265 out of 5 Stars
The physicians caring for my mother demonstrated the spirit of the Hippocratic Oath by carefully balancing treatment effectiveness with quality of life, ensuring that their decisions aligned with doing no harm and acting in her best interest.
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.